| Designing a broad-spectrum integrative approach for cancer prevention and treatment KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ... Seminars in cancer biology 35, S276-S304, 2015 | 305 | 2015 |
| Dysregulated metabolism contributes to oncogenesis MD Hirschey, RJ DeBerardinis, AME Diehl, JE Drew, C Frezza, MF Green, ... Seminars in cancer biology 35, S129-S150, 2015 | 303 | 2015 |
| Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer A Elgogary, Q Xu, B Poore, J Alt, SC Zimmermann, L Zhao, J Fu, B Chen, ... Proceedings of the National Academy of Sciences 113 (36), E5328-E5336, 2016 | 221 | 2016 |
| Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources AR Kim, IZ Hartman, B Poore, T Boronina, RN Cole, N Song, MT Ciudad, ... Nature communications 5 (1), 5369, 2014 | 59 | 2014 |
| Allosteric glutaminase inhibitors based on a 1, 4-di (5-amino-1, 3, 4-thiadiazol-2-yl) butane scaffold SC Zimmermann, EF Wolf, A Luu, AG Thomas, M Stathis, B Poore, ... ACS medicinal chemistry letters 7 (5), 520-524, 2016 | 57 | 2016 |
| A broad-spectrum integrative design for cancer prevention and therapy KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ... Seminars in cancer biology 35 (Suppl), S276, 2015 | 41 | 2015 |
| Unbiased metabolic profiling predicts sensitivity of high MYC-expressing atypical teratoid/rhabdoid tumors to glutamine inhibition with 6-diazo-5-oxo-L-norleucine SZ Wang, B Poore, J Alt, A Price, SJ Allen, AR Hanaford, H Kaur, BA Orr, ... Clinical Cancer Research 25 (19), 5925-5936, 2019 | 24 | 2019 |
| Inhibition of mTORC1 in pediatric low-grade glioma depletes glutathione and therapeutically synergizes with carboplatin B Poore, M Yuan, A Arnold, A Price, J Alt, JA Rubens, BS Slusher, ... Neuro-oncology 21 (2), 252-263, 2019 | 24 | 2019 |
| Molecular heterogeneity and cellular diversity: implications for precision treatment in medulloblastoma H Zou, B Poore, A Broniscer, IF Pollack, B Hu Cancers 12 (3), 643, 2020 | 19 | 2020 |
| Ciudad, MT; Caspi, RR; Jaraquemada, D.; Sadegh-Nasseri, S. Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources A Kim, IZ Hartman, B Poore, T Boronina, RN Cole, N Song Nat. Commun 5, 5369, 2014 | 19 | 2014 |
| Comparison of symptoms and antibody response following administration of Moderna or Pfizer SARS-CoV-2 vaccines MT Kelliher, JJ Levy, RD Nerenz, B Poore, AA Johnston, AR Rogers, ... Archives of Pathology & Laboratory Medicine 146 (6), 677-685, 2022 | 13 | 2022 |
| PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status AM Martin, WR Bell, M Yuan, L Harris, B Poore, A Arnold, EL Engle, ... Journal of Neuropathology & Experimental Neurology 79 (1), 74-85, 2020 | 13 | 2020 |
| Comprehensive metabolic profiling of myc-amplified medulloblastoma tumors reveals key dependencies on amino acid, tricarboxylic acid and hexosamine pathways K Pham, AR Hanaford, BA Poore, MJ Maxwell, H Sweeney, ... Cancers 14 (5), 1311, 2022 | 11 | 2022 |
| A neurodevelopmental epigenetic programme mediated by SMARCD3–DAB1–Reelin signalling is hijacked to promote medulloblastoma metastasis H Zou, B Poore, EE Brown, J Qian, B Xie, E Asimakidou, V Razskazovskiy, ... Nature cell biology 25 (3), 493-507, 2023 | 9 | 2023 |
| A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays B Poore, RD Nerenz, D Brodis, CI Brown, MA Cervinski, JA Hubbard Clinical Biochemistry 95, 77-80, 2021 | 9 | 2021 |
| Ciudad MT, Caspi RR, Jaraquemada D, Sadegh-Nasseri S (2014) Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources A Kim, IZ Hartman, B Poore, T Boronina, RN Cole, N Song Nat Commun 5, 5369, 0 | 7 | |
| TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma RE Maynard, B Poore, AR Hanaford, K Pham, M James, J Alt, Y Park, ... Cancer letters 504, 137-145, 2021 | 6 | 2021 |
| Gamma Glutamyl Transferase Activity Has Limited Utility in Assessment of Alkaline Phosphatase Elevations KA Geno, B Poore, MA Cervinski, RD Nerenz The Journal of Applied Laboratory Medicine 6 (6), 1623-1627, 2021 | 2 | 2021 |
| Metabolic characterization of follicular lymphoma transformation B Poore, A Ortega-Molina, C Nguyen, L Zhao, A Blackwell, T Hartung, ... Cancer Research 75 (15_Supplement), 1183-1183, 2015 | 2 | 2015 |
| Glucose-independent glutamine-driven TCA cycle in cancer cells B Poore, N Siegel, JK Park, BJ Hwang, I Afif, A Le Glutamine in Clinical Nutrition, 77-85, 2015 | 2 | 2015 |
